TLR4 and breast carcinoma: Real time PCR revealed that the expression of TLR4 on both human breast cancer cell lines was blocked by TLR4 antagonist which was added prior to the addition of LPS in ER+LPS group compared with LPS group (P<0.05)(Fig. 6A).